Table 1:
Baseline Characteristics of Patients
| Colistin Group (n = 73) | Placebo Group (n = 71) | |
|---|---|---|
| Sex, n (%) | ||
| Male | 27 (37%) | 34 (48%) |
| Female | 46 (63%) | 37 (52%) |
| Age, yr, mean (SD) | 58.3 (15.3) | 60.3 (15.8) |
| FEV1, L, mean (SD) | 1.55 (0.89) | 1.56 (0.65) |
| Predicted FEV1, %, mean (SD) | 55.9 (24.3) | 57.6 (24.9) |
| Weight of sputum collected over 24 h (g) before baseline visit, mean (SD) | 28.0 (25.9) | 28.6 (20.1) |
| Azithromycin therapy, n (%) | 6 (8%) | 5 (7%) |
| Prior inhaled antibiotic therapy | 0 | 0 |